Molecular evidence for increased antitumor activity of gemcitabine by genistein in vitro and in vivo using an orthotopic model of pancreatic cancer

Journal article

Open access

Peer reviewed

Sanjeev Banerjee, YUXIANG Zhang, Shadan Ali, Mohammad Bhuiyan, ZHIWEI Wang, Paul J Chiao, Philip A Philip, James Abbruzzese and Fazlul H Sarkar

Cancer research (Chicago, Ill.), Vol.65(19), pp.9064-9072

2005

PMID: 16204081

Abstract

Antineoplastic agents

Biological and medical sciences

Chemotherapy

Gastroenterology. Liver. Pancreas. Abdomen

Liver. Biliary tract. Portal circulation. Exocrine pancreas

Medical sciences

Pharmacology. Drug treatments

Tumors

url

https://doi.org/10.1158/0008-5472.CAN-05-1330View

Published (Version of record) Open

1 Record Views

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types: Domestic collaboration
Citation topics: 1 Clinical & Life Sciences; 1.141 Hormone Therapy; 1.141.1367 Isoflavones
Web Of Science research areas: Oncology
ESI research areas: Clinical Medicine

This output has contributed to the advancement of the following goals:

Source: InCites

Title: Molecular evidence for increased antitumor activity of gemcitabine by genistein in vitro and in vivo using an orthotopic model of pancreatic cancer
Creators: Sanjeev Banerjee - Wayne State University
YUXIANG Zhang - Wayne State University
Shadan Ali - Wayne State University
Mohammad Bhuiyan - Wayne State University
ZHIWEI Wang - Wayne State University
Paul J Chiao - Molecular & Cellular Oncology
Philip A Philip - Wayne State University
James Abbruzzese - The University of Texas MD Anderson Cancer Center
Fazlul H Sarkar - Wayne State University
Publication Details: Cancer research (Chicago, Ill.), Vol.65(19), pp.9064-9072
Publisher: American Association for Cancer Research
Academic Unit: Miller School of Medicine; UMMG Dept of Medicine - Hematology/Oncology
Language: English
Resource Type: Journal article
PMID: 16204081
Record Identifier: 991031713847802976